PLAUR and head and neck cancer: In these three OSCC PDX models, we studied the use of [64Cu]Cu-uPAR-PET/CT for imaging in a total of 29 tumors, a modality that has not previously been evaluated in head and neck cancer patients nor in heterogeneous preclinical PDX tumor models.